确定阿迪普辛作为2型糖尿病患者β细胞功能的生物标志物
Jae-Hyung Park1, Thi Nhi Nguyen1, Hye Min Shim1
1Department of Physiology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
Journal of clinical medicine
|December 17, 2024
概括
阿迪普辛是一种阿迪波金,在2型糖尿病 (T2D) 中显示为胰腺β细胞功能的生物标志物. 较低的素水平与T2D患者的β细胞功能降低相关,表明其诊断潜力.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 生物标志物发现发现
背景情况:
- 一种阿迪波金 (adipokine) 的阿迪普辛 (adipsin) 在小鼠模型中被认为具有维持胰腺β细胞功能的作用.
- 2型糖尿病 (T2D) 的特征是β细胞功能受损,需要可靠的生物标志物进行评估.
研究的目的:
- 调查阿迪普辛作为循环生物标记物的潜力,以评估T2D人类患者的胰腺β细胞功能.
- 探索不同T2D患者队列和小鼠模型中血腺素度和β细胞功能指标之间的关系.
主要方法:
- 血腺素度通过免疫检测测测量在正常血糖患者和T2D患者 (有或没有胰岛素治疗).
- 在小鼠模型中分析了阿迪普辛表达和相关的代谢参数,包括正常饮食,高脂肪饮食 (HFD) 和带有链毒素/尼古丁胺胺 (STZ/NA) 诱导的HFD.
主要成果:
- 在接受胰岛素治疗的T2D患者中,与未接受胰岛素治疗的患者相比,血素水平显著降低.
- 血腺素度与糖尿病患者的C-水平和C-原体指数呈正相关.
- 由HFD诱导和胰岛素缺乏的T2D小鼠模型表现出改变的素水平和表达,反映了β细胞功能和胰腺小岛大小的变化.
结论:
- 在2型糖尿病患者中,血素水平与胰腺β细胞功能有显著的关联.
- 阿迪普辛可以作为一种有价值的循环生物标志物,用于评估T2D背景下的β细胞功能.
- 对素作用的进一步研究可以提高T2D管理和诊断.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
167
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
167
Insulin: Biosynthesis, Chemistry, and Preparation
355
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
355
Glucagon-like Receptor Agonists
297
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
297
Diabetes: Symptoms, Diagnosis, and Complications
503
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
503
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Insulin: The Receptor and Signaling Pathways
1.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K


